Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance.

Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance.
复制标题

DOI:
10.18632/oncotarget.23186
复制
发表时间:
2018-01-09
期刊:
影响因子:
--
通讯作者:
Rø TB
Rø TB
中科院分区:
其他
文献类型:
--
作者:
Hjort MA;Abdollahi P;Vandsemb EN;Fenstad MH;Lund B;Slørdahl TS;Børset M;Rø TB

文献摘要

参考文献

被引文献

相似文献

再生肝磷酸酶-3(PRL-3/PTP4A3)在多种肿瘤中表达上调,包括BCR-ABL1和ETV6-RUNX阳性的急性淋巴细胞白血病(ALL)。本研究旨在研究PRL-3在B细胞急性淋巴细胞白血病(B-ALL)中的生物学作用。在这里,我们证明,通过qRT-PCR或流式细胞仪检测,B-ALL细胞在mRNA和蛋白水平上的PRL-3表达高于正常细胞。此外,我们证明,使用shRNA或小分子抑制剂抑制Prl-3可以减少Preb-ALL细胞系REH和MHH-CALL-4中细胞向SDF-1α梯度的迁移。PRL-3基因敲除也减少了REH细胞对纤维连接蛋白的黏附。在机制上,PRL-3介导的SDF-1α刺激钙释放,并激活粘着斑激酶和sRc,它们是迁移和黏附的重要影响因素。PRL-3的表达使REH细胞对阿糖胞苷具有更强的耐药性。结论:B-ALL细胞中PRL-3的表达水平高于正常细胞。PRL-3促进细胞对阿糖胞苷的黏附、迁移和耐药性。PRL-3可能是治疗B-ALL的一个新靶点。
Phosphatase of regenerating liver-3 (PRL-3/PTP4A3) is upregulated in multiple cancers, including BCR-ABL1- and ETV6-RUNX-positive acute lymphoblastic leukemia (ALL). With this study, we aim to characterize the biological role of PRL-3 in B cell ALL (B-ALL). Here, we demonstrate that PRL-3 expression at mRNA and protein level was higher in B-ALL cells than in normal cells, as measured by qRT-PCR or flow cytometry. Further, we demonstrate that inhibition of PRL-3 using shRNA or a small molecular inhibitor reduced cell migration towards an SDF-1α gradient in the preB-ALL cell lines Reh and MHH-CALL-4. Knockdown of PRL-3 also reduced cell adhesion towards fibronectin in Reh cells. Mechanistically, PRL-3 mediated SDF-1α stimulated calcium release, and activated focal adhesion kinase (FAK) and Src, important effectors of migration and adhesion. Finally, PRL-3 expression made Reh cells more resistance to cytarabine treatment. In conclusion, the expression level of PRL-3 was higher in B-ALL cells than in normal cells. PRL-3 promoted adhesion, migration and resistance to cytarabine. PRL-3 may represent a novel target in the treatment of B-ALL.
DOI: 10.1016/j.canlet.2016.07.017
发表时间: 2016-10-01
期刊: Cancer letters
影响因子: 9.7
作者:
Gari HH;DeGala GD;Ray R;Lucia MS;Lambert JR
通讯作者: Lambert JR
DOI: 10.3389/fonc.2014.00099
发表时间: 2014
影响因子: 4.7
作者:
Shishido S;Bönig H;Kim YM
通讯作者: Kim YM
DOI: 10.1126/science.1065817
发表时间: 2001-11-09
期刊: SCIENCE
影响因子: 56.9
作者:
Saha, S;Bardelli, A;Vogelstein, B
通讯作者: Vogelstein, B
DOI: 10.1038/sj.leu.2401729
发表时间: 2000-05-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Bradstock, KF;Makrynikola, V;Gottlieb, DJ
通讯作者: Gottlieb, DJ
DOI: 10.1038/sj.leu.2404769
发表时间: 2007-08-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Glodek, A. M.;Le, Y.;Silberstein, L. E.
通讯作者: Silberstein, L. E.